Thursday, 13 May 2010- MDV3100 is a novel oral androgen receptor (AR) antagonist. It was designed to bind the AR with greater affinity and prevent nuclear translocation of AR with greater efficiency than bicalutamide.

Unlike...

Wednesday, 12 May 2010- The inclusion of an apical core, particularly an extreme apical core, in initial trans-rectal ultrasound (TRUS)-guided biopsy increases the detection of prostate cancer, say US researchers.

The team...

Tuesday, 11 May 2010- Men from lower socioeconomic groups in the United Kingdom were less likely to undergo radiotherapy or prostatectomy to treat prostate cancer. This trend persisted even after factors such as hospital of...

Tuesday, May 11 2010-  A technique that urologists had hoped would make it possible to distinguish men with prostate cancer who need treatment from those who would only need watchful waiting didn't work well, according to a...

Tuesday, 11 May 2010- Gonadotropin-releasing hormone (GnRH) agonists, a class of medications primarily used to treat men with prostate cancer, have been associated with a small increased risk for diabetes, heart attack, stroke,...

Monday, 10 May 2010- The free prostate-specific antigen (PSA) isoform, [-2]proPSA, has been shown to be associated with prostate cancer. A group of US researchers conducted a study to characterise the clinical utility of serum...

Friday, 7 May 2010- A group of French researchers evaluated the pathological characteristics of prostate specimen after radical prostatectomy performed in low risk patients eligible for active surveillance (AS).

J.B. Beauval and...

Thursday, 6 May 2010- Despite the large number of men diagnosed with localised prostate cancer, there is as yet no consensus concerning appropriate treatment.

M. J. Schymura and colleagues conducted a study to describe the...

Wednesday, 5 May 2010- The U.S. Food and Drug Administration (FDA) approved Provenge (sipuleucel-T), a new therapy for certain men with advanced prostate cancer that uses their own immune system to fight the disease.

Provenge...

Thursday, 6 May 2010- Prostate cancer patients who are eligible for active surveillance may actually benefit from robotic-assisted laparoscopic prostatectomy (RALP), according to data announced at the 25th Anniversary EAU...

Tuesday, 4 May 2010-  MDV3100 is a novel oral androgen receptor (AR) antagonist. It was designed to bind the AR with greater affinity and prevent nuclear translocation of AR with greater efficiency than bicalutamide....

Friday, 30 April 2010- The prostate gland represents a multifaceted system in which prostate epithelia and stroma have distinct physiological roles. To understand the interaction between stroma and glandular epithelia, it is...

Thursday, 29 April 2010- Watson Pharmaceuticals has received FDA approval of Trelstar (triptorelin pamoate for injectable suspension) 22.5 mg, the first and only six-month intramuscular gonadotropin releasing hormone (GnRH)...

Wednesday, 28 April 2010- The anticipated approval this week of a therapeutic prostate cancer vaccine by the US Food and Drug Administration could be a milestone against the disease and cancer in general, experts say.

The...

Wednesday, 28 April 2010- Obese men and men who gained weight after prostatectomy were found to be at increased risk for prostate cancer recurrence. Researchers said the risk was even greater for men who are sedentary or...

Thursday, 8 July 2010- Bone-density screening can be cost effective after prostate cancer treatment, a new study has found.

According to background information cited in the study, androgen deprivation therapy (ADT), which is...

Tuesday, 6 July 2010- Progress toward understanding the role of sex hormones in the growth of prostate cancer has been hindered by the lack of a suitable laboratory research model. Now researchers say they have developed the...

Monday, 5 July 2010- Progress toward understanding the role of sex hormones in the growth of prostate cancer has been hindered by the lack of a suitable laboratory research model. Now US researchers say they have developed the...

Friday, 2 July 2010- Researchers at the Uniformed Services University of the Health Sciences (USU) Center for Prostate Disease Research (CPDR), in collaboration with investigators at the Armed Forces Institute of Pathology (AFIP)...